OneChain Immunotherapeutics

Logo OneChain Immunotherapeutics

Contact information

OneChain Immunotherapeutics
Jorge Alemany, CEO
C/ Muntaner 383, 3º 2ª
+34 609149992
Areas of activities
  • A. Health Biotechnology
    • Therapeutic areas
      • Oncology
      • Blood and lymphatic system

To develop CAR-T cell products for the treatment of hemato-oncology diseases.

Products and services
  1. CAR-T CD1a for the treatment of T cell Acute Lymphoblastic Leukemia
  2. Allogeneic DOTs platform
Areas of interest for future collaborations

Companies interested in cancer treatment with immune products.